InsidersTradesSigma
오리엔트바이오: insider trades · South Korea · DART (FSS)
DART:company-c212e0KR·DART (FSS)Mcap 187.8Bn€
Discover the full insider trade history of 오리엔트바이오, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Market capitalisation: €187.8bn. The latest transaction was reported on 20 March 2026 — Purchase. Among the most active insiders: 오리엔트. The full history is openly available.
2
Insider Decl.
0
Thresholds
·
1 ops.
Buy Volume
·
1 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
483.00 €
Income statement
Revenue29.40 Bn€
Gross profit7.20 Bn€24% margin
Net income−13.19 Bn€-44.9% margin
Balance sheet & cash
Market cap187.81 Bn€
Total debt2.62 Bn€
Free Cash Flow−4.04 Bn€
Last declaration on 20 March 2026